This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: University System of Maryland, Regeneron Pharmaceuticals, Inc.. Active years: 2020-2025.
Company Filing History:
2 out of 2,022 
1 out of 1,473 
Years Active: 2020-2025
Title: May Montasser: Innovator in Cardiovascular Research
Introduction
May Montasser is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of cardiovascular research, holding 2 patents that focus on innovative methods and compositions related to B4GALT1 variants.
Latest Patents
Montasser's latest patents include groundbreaking work on B4GALT1 cDNA variants and their applications. These patents encompass various aspects, such as genomic, mRNA, and cDNA nucleic acid molecules, along with polypeptides. His inventions provide methods for detecting the presence of these molecules, modulating endogenous B4GALT1, and ascertaining the risk of developing cardiovascular conditions. Additionally, they offer methods for treating cardiovascular conditions, showcasing the potential impact of his work on healthcare.
Career Highlights
Throughout his career, May Montasser has worked with prominent organizations, including Regeneron Pharmaceuticals, Inc. and the University System of Maryland. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Some of his notable coworkers include Cristopher Van Hout and Giusy Della Gatta, who have collaborated with him on various projects, enhancing the scope and impact of his research.
Conclusion
May Montasser's innovative work in cardiovascular research and his patents on B4GALT1 variants highlight his significant contributions to the field. His collaborations and career experiences further underscore his role as a leading inventor in this important area of study.